Page last updated: 2024-10-22

amiodarone and Ductus Arteriosus, Patent

amiodarone has been researched along with Ductus Arteriosus, Patent in 2 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Ductus Arteriosus, Patent: A congenital heart defect characterized by the persistent opening of fetal DUCTUS ARTERIOSUS that connects the PULMONARY ARTERY to the descending aorta (AORTA, DESCENDING) allowing unoxygenated blood to bypass the lung and flow to the PLACENTA. Normally, the ductus is closed shortly after birth.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbosa Lopes, AA1
Scalabrini Neto, A1
Barbosa, SA1
Tranchesi, J1

Other Studies

2 other studies available for amiodarone and Ductus Arteriosus, Patent

ArticleYear
Index of suspicion.
    Pediatrics in review, 2002, Volume: 23, Issue:9

    Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Child; Cranial Nerve Neoplasms; Digoxin; Down Syndrome; D

2002
[Wolff-Parkinson-White syndrome associated with morphology of complete left bundle branch block in a person with patent ductus arteriosus].
    Arquivos brasileiros de cardiologia, 1978, Volume: 31, Issue:2

    Topics: Amiodarone; Bundle of His; Bundle-Branch Block; Ductus Arteriosus, Patent; Electrocardiography; Hear

1978